1. Home
  2. ZYBT

as 07-25-2025 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
.
-
-
%

Stocks

NYSE

Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs and is available in 29 provincial regions across China and are exported overseas to Vietnam, Pakistan and Egypt.

Founded: 2004 Country:
China
China
Employees: N/A City: N/A
Market Cap: 340.3M IPO Year: 2025
Target Price: N/A AVG Volume (30 days): 76.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.03 EPS Growth: -64.04
52 Week Low/High: $3.50 - $14.30 Next Earning Date: 07-03-2025
Revenue: $25,531,367 Revenue Growth: -11.95%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: